Gambling disorders, gambling type preferences, and psychiatric comorbidity among the Thai general population: Results of the 2013 National Mental Health Survey

Background and aims To estimate the prevalence of problem and pathological gambling, gender and age-group differences in gambling types, and comorbidities with other psychiatric disorders among the Thai general population. Methods Analysis was conducted on 4,727 participants of Thailand’s 2013 National Mental Health Survey, a multistage stratified cluster survey, using the Composite International Diagnostic Interview. Diagnoses of problem and pathological gambling and other psychiatric disorders were based on the DSM-IV-TR criteria with the following additional criteria for gamblers: more than 10 lifetime gambling episodes and a single year loss of at least 365 USD from gambling. Results The estimated lifetime prevalence rates of pathological and problem gambling were 0.90% [95% confidence interval (CI): 0.51–1.29] and 1.14% (95% CI: 0.58–1.70), respectively. The most popular type of gambling was playing lotteries [69.5%, standard error (SE) = 1.9], the prevalence of which was significantly higher among females and older age groups. The most common psychiatric disorders seen among pathological gamblers were alcohol abuse (57.4%), nicotine dependence (49.5%), and any drug use disorder (16.2%). Pathological gambling was highly prevalent among those who ever experienced major depressive episodes (5.5%), any drug dependence (5.1%), and intermittent explosive disorder (4.8%). The association between pathological gambling was strongest with a history of major depressive episode [adjusted odds ratio (AOR) = 10.4, 95% CI: 2.80–38.4]. Conclusion The study confirms the recognition of gambling disorders as a public health concern in Thailand and suggests a need for culturally specific preventive measures for pathological gamblers and those with a history of substance use disorders or major depression

Modeling the Formation of Giant Planet Cores I: Evaluating Key Processes

One of the most challenging problems we face in our understanding of planet formation is how Jupiter and Saturn could have formed before the the solar nebula dispersed. The most popular model of giant planet formation is the so-called 'core accretion' model. In this model a large planetary embryo formed first, mainly by two-body accretion. This is then followed by a period of inflow of nebular gas directly onto the growing planet. The core accretion model has an Achilles heel, namely the very first step. We have undertaken the most comprehensive study of this process to date. In this study we numerically integrate the orbits of a number of planetary embryos embedded in a swarm of planetesimals. In these experiments we have included: 1) aerodynamic gas drag, 2) collisional damping between planetesimals, 3) enhanced embryo cross-sections due to their atmospheres, 4) planetesimal fragmentation, and 5) planetesimal driven migration. We find that the gravitational interaction between the embryos and the planetesimals lead to the wholesale redistribution of material - regions are cleared of material and gaps open near the embryos. Indeed, in 90% of our simulations without fragmentation, the region near that embryos is cleared of planetesimals before much growth can occur. The remaining 10%, however, the embryos undergo a burst of outward migration that significantly increases growth. On timescales of ~100,000 years, the outer embryo can migrate ~6 AU and grow to roughly 30 Earth-masses. We also find that the inclusion of planetesimal fragmentation tends to inhibit growth.Comment: Accepted to AJ, 62 pages 11 figure

Sap flow velocities of Acer saccharum and Quercus velutina during drought: Insights and implications from a throughfall exclusion experiment in West Virginia, USA

Forest species composition mediates evapotranspiration and the amount of water available to human-use downstream. In the last century, the heavily forested Appalachian region has been undergoing forest mesophication which is the progressive replacement of xeric species (e.g. black oak (Quercus velutina)) by mesic species (e.g. sugar maple (Acer saccharum)). Given differences between xeric and mesic species in water use efficiency and rainfall interception losses, investigating the consequences of these species shifts on water cycles is critical to improving predictions of ecosystem responses to climate change. To meet this need, we quantified the degree to which the sap velocities of two dominant broadleaved species (sugar maple and black oak) in West Virginia, responded to ambient and experimentally altered soil moisture conditions using a throughfall exclusion experiment. We then used these data to explore how predictions of future climate under two emissions scenarios could affect forest evapotranspiration rates. Overall, we found that the maples had higher sap velocity rates than the oaks. Sap velocity in maples showed a stronger sensitivity to vapor pres-sure deficit (VPD), particularly at high levels of VPD, than sap velocity in oaks. Experimentally induced reductions in shallow soil moisture did not have a relevant impact on sap velocity. In response to future climate scenarios of in-creased vapor pressure deficits in the Central Appalachian Mountains, our results highlight the different degrees to which two important tree species will increase transpiration, and potentially reduce the water available to the heavily populated areas downstream

Predictors for presence and abundance of small mammals in households of villages endemic for commensal rodent plague in Yunnan Province, China

<p>Abstract</p> <p>Background</p> <p>Ninety-one rodent plague epidemics have occurred in Lianghe county, Yunnan Province, China, between 1990 and 2006. This study aimed to identify predictors for the presence and abundance of small mammals in households of villages endemic for rodent plague in Lianghe county.</p> <p>Results</p> <p><it>Rattus flavipectus </it>and <it>Suncus murinus </it>were the two species captured in 110 households. Keeping cats decreased the number of captures of <it>R. flavipectus </it>by one to two thirds and the chance of reported small mammal sightings in houses by 60 to 80%. Food availability was associated with fewer captures. Keeping food in sacks decreased the small mammal captures, especially of <it>S. murinus </it>4- to 8-fold. Vegetables grown around house and maize grown in the village reduced the captures of <it>S. murinus </it>and <it>R. flavipectus </it>by 73 and 45%, respectively. An outside toilet and garbage piles near the house each reduced <it>R. flavipectus </it>captures by 39 and 37%, respectively, while raising dogs and the presence of communal latrines in the village increased <it>R. flavipectus </it>captures by 76 and 110% but were without detectable effect on small mammal sightings. Location adjacent to other houses increased captures 2-fold but reduced the chance of sightings to about half. In addition, raising ducks increased the chance of sighting small mammals 2.7-fold. Even after adjusting for these variables, households of the Dai had higher captures than those of the Han and other ethnic groups.</p> <p>Conclusion</p> <p>Both species captures were reduced by availability of species-specific foods in the environment, whereas other predictors for capture of the two species differed. Other than the beneficial effect of cats, there were also discrepancies between the effects on small mammal captures and those on sightings. These differences should be considered during the implementation and interpretation of small mammal surveys.</p

Rate of Decline in Nontreponemal Antibody Titers and Seroreversion After Treatment of Early Syphilis

Syphilis management is complex and demonstration of treatment response requires monitoring of nontreponemal antibody titers for a ≥ 4-fold decline and/or seroreversion to nonreactive titers

The TREAT-NMD advisory committee for therapeutics (TACT): an innovative de-risking model to foster orphan drug development

Despite multiple publications on potential therapies for neuromuscular diseases (NMD) in cell and animal models only a handful reach clinical trials. The ability to prioritise drug development according to objective criteria is particularly critical in rare diseases with large unmet needs and a limited numbers of patients who can be enrolled into clinical trials. TREAT-NMD Advisory Committee for Therapeutics (TACT) was established to provide independent and objective guidance on the preclinical and development pathway of potential therapies (whether novel or repurposed) for NMD. We present our experience in the establishment and operation of the TACT. TACT provides a unique resource of recognized experts from multiple disciplines. The goal of each TACT review is to help the sponsor to position the candidate compound along a realistic and well-informed plan to clinical trials, and eventual registration. The reviews and subsequent recommendations are focused on generating meaningful and rigorous data that can enable clear go/no-go decisions and facilitate longer term funding or partnering opportunities. The review process thereby acts to comment on viability, de-risking the process of proceeding on a development programme. To date TACT has held 10 review meeting and reviewed 29 program applications in several rare neuromuscular diseases: Of the 29 programs reviewed, 19 were from industry and 10 were from academia; 15 were for novel compounds and 14 were for repurposed drugs; 16 were small molecules and 13 were biologics; 14 were preclinical stage applications and 15 were clinical stage applications. 3 had received Orphan drug designation from European Medicines Agency and 3 from Food and Drug Administration. A number of recurrent themes emerged over the course of the reviews and we found that applicants frequently require advice and education on issues concerned with preclinical standard operating procedures, interactions with regulatory agencies, formulation, repurposing, clinical trial design, manufacturing and ethics. Over the 5 years since its establishment TACT has amassed a body of experience that can be extrapolated to other groups of rare diseases to improve the community's chances of successfully bringing new rare disease drugs to registration and ultimately to marke